Novel therapeutic strategy for melanoma based on albendazole and the CDK4/6 inhibitor palbociclib

Although an increasing number of patients benefit from immunotherapy and targeted therapies, melanoma remains incurable with increasing incidence. Drug repositioning and repurposing is an alternative strategy to discover and develop novel anticancer drugs or combined therapeutic regimens. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lin, Yang, Qin, Hu, Rong, Li, Yanan, Peng, Yuanliang, Liu, Hong, Ye, Mao, Zhang, Bin, Zhang, Peihe, Liu-Smith, Feng, Li, Hui, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983746/
https://www.ncbi.nlm.nih.gov/pubmed/35383224
http://dx.doi.org/10.1038/s41598-022-09592-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983746/
https://www.ncbi.nlm.nih.gov/pubmed/35383224
http://dx.doi.org/10.1038/s41598-022-09592-0

Ejemplares similares